CAS No.: 203120-46-1
Laninamivir octanoate Catalog No. CSN20464
Synonyms: CS-8958;Laninamivir Octanoate;R-125489
Laninamivir octanoate is a neuraminidase inhibitor that exhibits clinical efficacy for both treatment and prophylaxis of influenza virus infection, resulting from hydrolytic bioactivation into its pharmacologically active metabolite laninamivir in the pulmonary tissue.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT00657111 Influenza Phase 1 Completed - United Kingdom ... more >> Covance Clinical Research Unit Ltd (Covance CRU) Leeds, United Kingdom, LS2 9LH Collapse << NCT00995826 Influenza Phase 1 Completed - United Kingdom ... more >> Covance Clinical Research Unit Limited Leeds, United Kingdom Collapse << NCT01793883 - - Completed - - - 更多
- 参考文献
- [1] Kashiwagi S, Watanabe A, et al. Laninamivir octanoate for post-exposure prophylaxis of influenza in household contacts: a randomized double blind placebo controlled trial. J Infect Chemother. 2013 Aug;19(4):740-9.
- [2] Sugaya N, Ohashi Y. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob Agents Chemother. 2010 Jun;54(6):2575-82.
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 203120-46-1 | 储存条件 |
|
|
| 分子式 | C21H36N4O8 | 运输 | 蓝冰 | |
| 分子量 | 472.53 | 别名 | CS-8958;Laninamivir Octanoate;R-125489 |
